Tenax Therapeutics amended the employment agreements of Christopher Giordano, Stuart Rich and Thomas Staab to provide specified severance and related benefits, conditioned on execution of a release of claims.
| IndividualChristopher GiordanoStuart RichThomas Staab | RoleExecutive (party to amended employment agreement)Executive (party to amended employment agreement)Executive (party to amended employment agreement) | Type of ChangeEmployment agreement amendedEmployment agreement amendedEmployment agreement amended | Effective DateJune 26, 2026June 26, 2026June 26, 2026 | ReasonTo provide severance and related benefits in lieu of participation in new CIC and Severance Plans; conditioned on release of claimsTo provide severance and related benefits in lieu of participation in new CIC and Severance Plans; conditioned on release of claimsTo provide severance and related benefits in lieu of participation in new CIC and Severance Plans; conditioned on release of claims | Replacement InfoNot disclosedNot disclosedNot disclosed | Background DetailsNot disclosed in Item 5.02 beyond being an executive party to an employment agreementEntitled to accelerated vesting of outstanding equity awards upon change-in-control termination; otherwise party to amended agreementNot disclosed in Item 5.02 beyond being an executive party to an employment agreement | Board/Committee Role ChangesNot disclosedNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.